FREE Account Opening + No Clearing Fees
Loading...

Gensol Engineering IPO vs Par Drugs IPO

Comparision between Gensol Engineering IPO and Par Drugs IPO.

IPO Details

Gensol Engineering IPO is a SME Fixed Price Issue IPO proposed to list at BSE SME while Par Drugs IPO is a SME Fixed Price Issue proposed to list at NSE SME.

  Gensol Engineering IPO Par Drugs IPO
Logo Gensol Engineering IPO Logo Par Drugs IPO Logo
Issue Category SME SME
Issue Type IPO IPO
Process Type Book Built Issue Fixed Price Issue
Listing At BSE SME NSE SME
Lead Managers Pantomath Capital Advisors Pvt Ltd Pantomath Capital Advisors Pvt Ltd
Registrar Link Intime India Private Ltd Link Intime India Private Ltd
Market Maker
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor
IPO Allotment URL IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Gensol Engineering IPO is up to ₹17.93 Cr whereas the issue size of the Par Drugs IPO is up to ₹8.53 Cr. The final issue price of Gensol Engineering IPO is ₹83.00 per share and of Par Drugs IPO is ₹51.00 per share.

  Gensol Engineering IPO Par Drugs IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower) ₹81.00 per share
Issue Price (Upper) ₹83.00 per share
Issue Price (Final) ₹83.00 per share ₹51.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 1600 shares 2000 shares
Fresh Issue Size 16,72,000 shares
Fresh Issue Size (Amount)
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total 21,60,000 shares 16,72,000 shares
Issue Size Total (Amount) up to ₹17.93 Cr up to ₹8.53 Cr

IPO Timetable

Gensol Engineering IPO opens on Sep 30, 2019, while Par Drugs IPO opens on May 03, 2019. The closing date of Gensol Engineering IPO and Par Drugs IPO is Oct 04, 2019, and May 08, 2019, respectively.

  Gensol Engineering IPO Par Drugs IPO
Anchor Bid Date
Issue Open Sep 30, 2019 May 03, 2019
Issue Close Oct 04, 2019 May 08, 2019
Basis Of Allotment (Tentative) Oct 10, 2019 May 13, 2019
Initiation of Refunds (Tentative) Oct 11, 2019 May 14, 2019
Credit of Share (Tentative) Oct 14, 2019 May 15, 2019
Listing date (Tentative) Oct 15, 2019 May 16, 2019
Anchor Lockin End date 1 Nov 09, 2019 Jun 12, 2019
Anchor Lockin End date 2 Jan 08, 2020 Aug 11, 2019

Financials

Gensol Engineering IPO P/E ratio is , as compared to Par Drugs IPO P/E ratio of .

  Gensol Engineering IPO Par Drugs IPO
Financial
Summary of financial Information (Restated)
Particulars For the year/period ended (in Rs. Lakhs)
31-Mar-19 31-Mar-18 31-Mar-17
Total Assets 4,288.66 2,643.71 996.80
Total Revenue 8,385.43 6,964.42 6,231.77
Profit After Tax 649.68 533.66 118.90
Summary of financial Information (Restated)
Particulars For the year/period ended (in Rs. Lakhs)
31-Mar-19 31-Mar-18 31-Mar-17 31-Mar-16
Total Assets 5,135.55 5,393.89 5,604.14 5,803.08
Total Revenue 4,641.20 4,241.65 4,880.90 3,326.43
Profit After Tax 241.88 149.53 184.78 42.18
Promoter Shareholding (Pre-Issue) 96% 99.55%
Promoter Shareholding (Post-Issue) 70.72% 72.82
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Gensol Engineering IPO retail investors (RII) are offered 10,25,600 shares while in Par Drugs IPO retail investors are offered 10,25,600 shares. Qualified institutional buyers (QIB) are offered in Gensol Engineering IPO and in Par Drugs IPO.

  Gensol Engineering IPO Par Drugs IPO
Anchor Investor Reserveration
Market Maker Reserveration 1,08,800 shares 84,000 shares
QIB
NII 10,25,600 shares 7,78,000 shares
RII 10,25,600 shares 7,80,000 shares
Employee 30,000 shares
Others
Total 20,51,200 shares 15,58,000 shares

Bids Received (Subscription)

Gensol Engineering IPO subscribed 1.32x in total, whereas Par Drugs IPO subscribed 5.74x.

  Gensol Engineering IPO Par Drugs IPO
QIB (times)
NII (times) 2.27x 3.48x
Big NII (times)
Small NII (times)
RII (times) 0.37x 7.97x
Employee (times) 1.00x
Other (times)
Total (times) 1.32x 5.74x

Comments

Add a public comment...